Tenax Therapeutics, Inc.
TENXAs of the close on Sep 25, 2026
Price
$1.81
Market cap
—
The cover-page share count does not match the latest report's share count
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Tenax Therapeutics, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 15 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 13, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Independent insiders buying near the same time
- 2024-08-08–2024-08-08: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2024-08-08–2024-08-08: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2024-08-08–2024-08-08: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2013-07-23–2013-07-23: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2013-07-23–2013-07-23: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-09 | Rich Stuart · Chief Medical Officer | Common Stock | P — Open market or private purchase | +2,500 | 10.22 | SEC filing |
| 2025-12-08 | Rich Stuart · Chief Medical Officer | Common Stock | P — Open market or private purchase | +2,500 | 10.10 | SEC filing |
| 2025-12-04 | Rich Stuart · Chief Medical Officer | Common Stock | P — Open market or private purchase | +2,500 | 9.20 | SEC filing |
| 2025-12-03 | Rich Stuart · Chief Medical Officer | Common Stock | P — Open market or private purchase | +1,500 | 9.08 | SEC filing |
| 2025-12-02 | Rich Stuart · Chief Medical Officer | Common Stock | P — Open market or private purchase | +1,000 | 9.01 | SEC filing |
| 2025-11-20 | Giordano Christopher Thomas · CEO | Common Stock | P — Open market or private purchase | +538 | 7.59 | SEC filing |
| 2025-11-19 | Giordano Christopher Thomas · CEO | Common Stock | P — Open market or private purchase | +455 | 7.51 | SEC filing |
| 2025-11-18 | Almenoff June Sherie · Director | Common Stock | P — Open market or private purchase | +1,900 | 7.52 | SEC filing |
Showing 8 of 11 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-11 | STAAB THOMAS R II · Chief Financial Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +450,000 | SEC filing |
| 2026-05-11 | STAAB THOMAS R II · Chief Financial Officer | Common Stock | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-01-30 | MCGAULEY THOMAS · Interim CFO | Stock Option (right to buy) | M — Exercise or conversion of derivative security | +50,000 | SEC filing |
| 2026-01-09 | PROEHL GERALD T · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +3,000 | SEC filing |
| 2026-01-09 | Hunter Robyn · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-01-09 | Doogan Declan · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-01-09 | Almenoff June Sherie · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-01-09 | Giordano Christopher Thomas · CEO | Stock Option (right to buy) | A — Grant, award, or other acquisition | +450,000 | SEC filing |
Showing 8 of 35 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2022-05-18 | ARMISTICE CAPITAL, LLC · Director | Common Stock Purchase Warrants | D — Disposition to the issuer | −2,360,313 | SEC filing |
| 2022-05-18 | ARMISTICE CAPITAL, LLC · Director | Series B Common Stock Purchase Warrants | D — Disposition to the issuer | −3,175,924 | SEC filing |
| 2022-05-18 | ARMISTICE CAPITAL, LLC · Director | Common Stock Purchase Warrants | D — Disposition to the issuer | −2,072,538 | SEC filing |
| 2022-05-18 | ARMISTICE CAPITAL, LLC · Director | Warrant (right to buy) | D — Disposition to the issuer | −4,773,269 | SEC filing |
| 2022-05-18 | ARMISTICE CAPITAL, LLC · Director | Series C Common Stock Purchase Warrants | D — Disposition to the issuer | −4,607,692 | SEC filing |
| 2018-07-31 | Jebsen Michael B · CFO | common stock | D — Disposition to the issuer | +5,720 | SEC filing |
| 2018-03-30 | Jebsen Michael B · CFO | common stock | D — Disposition to the issuer | +6,425 | SEC filing |
| 2017-12-29 | Jebsen Michael B · CFO | common stock | D — Disposition to the issuer | +98 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.